Angiotensin receptor-neprilysin inhibitor for the treatment of heart failure: a review of recent evidence
Hong-Mi Choi, Mi-Seung Shin
Korean J Intern Med. 2020;35(3):498-513. Published online 2020 Apr 29 DOI: https://doi.org/10.3904/kjim.2020.105
Citations to this article as recorded by 
Irreversible myocardial injury attenuates the benefits of sacubitril/valsartan in heart failure patients
Hong-Mi Choi, In-Chang Hwang, Hye Jung Choi, Yeonyee E. Yoon, Hyun-Jung Lee, Jun-Bean Park, Seung-Pyo Lee, Hyung-Kwan Kim, Yong-Jin Kim, Goo-Yeong Cho
International Journal of Cardiology.2024; 397: 131611. CrossRef
Effects of sacubitril/valsartan versus olmesartan on left atrial structure in hypertensive patients without HFrEF: a randomized controlled trial
Peina Meng, Yajie Guo, Jing Dong, Zhiming Wu, Xiangqi Wu, Tianyi Huang, Wei You, Meili Ji, Haibo Jia, Fei Ye
Cardiology Plus.2024;[Epub] CrossRef
Obesity-related heart failure with preserved ejection fraction: diagnostic and therapeutic challenges
Mi-Hyang Jung, Mi-Seung Shin
The Korean Journal of Internal Medicine.2023; 38(2): 157. CrossRef
Neferine ameliorates hypertensive vascular remodeling modulating multiple signaling pathways in spontaneously hypertensive rats
Weiquan Zeng, Xiuli Zhang, Yao Lu, Ying Wen, Qiurong Xie, Xuan Yang, Shuyu He, Zhi Guo, Jiapeng Li, Aling Shen, Jun Peng
Biomedicine & Pharmacotherapy.2023; 158: 114203. CrossRef
Optimization of guideline-directed medical treatment for heart failure patients with reduced ejection fraction
Minjung Bak, Jin-Oh Choi
The Korean Journal of Internal Medicine.2023; 38(5): 595. CrossRef
Is there sufficient evidence to justify changes in dietary habits in heart failure patients? A systematic review
Alejandra García-García, Luis A. Alvarez-Sala-Walther, Hae-Young Lee, Cristina Sierra, Domingo Pascual-Figal, Miguel Camafort
The Korean Journal of Internal Medicine.2022; 37(1): 37. CrossRef
The Difference between Sacubitril Valsartan and Valsartan on Vascular Endothelial Function, APN, MMP-9, and BNP Levels in Patients with Hypertension and Chronic Heart Failure
Haiping Du, Xiao Li, Weifang Zhao, Ning Jiang, Bhagyaveni M.A
Journal of Healthcare Engineering.2022; 2022: 1. CrossRef
Molecular mechanisms of sacubitril/valsartan in cardiac remodeling
Nor Hidayah Mustafa, Juriyati Jalil, Satirah Zainalabidin, Mohammed S.M. Saleh, Ahmad Yusof Asmadi, Yusof Kamisah
Frontiers in Pharmacology.2022;[Epub] CrossRef
A clinical experience of Indian patients with heart failure with reduced left ventricular ejection fraction using an angiotensin receptor-neprilysin inhibitor [ARNI] on an outpatient basis
Pankaj Jariwala, Arshad Punjani, Harikishan Boorugu, Dilip Babu Madhawar
Indian Heart Journal.2021; 73(2): 211. CrossRef
Relationship between enteral nutrition and serum levels of inflammatory factors and cardiac function in elderly patients with heart failure
Shutang Zhao, Xiren Wang
Medicine.2021; 100(19): e25891. CrossRef
Efficacy and safety of early initiation of Sacubitril/Valsartan in patients after acute myocardial infarction: A meta‐analysis
Jing Zhao, Yuanyuan Zeng, Xiaoxu Shen
Clinical Cardiology.2021; 44(10): 1354. CrossRef
Multi-Antigen Imaging Reveals Inflammatory DC, ADAM17 and Neprilysin as Effectors in Keloid Formation
Mathias Rath, Alain Pitiot, Michael Kirr, Waltraud Fröhlich, Bianca Plosnita, Stefan Schliep, Jürgen Bauerschmitz, Andreas S. Baur, Christian Ostalecki
International Journal of Molecular Sciences.2021; 22(17): 9417. CrossRef